ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

Foundation offers funds for mesothelioma research.

July 9, 2004

DCE Board Oks Concept For Three Contracts In Radiation Epidemiology

June 29, 1984

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER

July 24, 1998